Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide.
Ambiq Micro has delivered a very large 170.9% year to date return, yet on the valuation checks the stock screens as expensive rather than a clear bargain.
-
The 170.9% gain year to date suggests investors have rapidly repriced Ambiq Micro for stronger prospects than were assumed at the start of the year.
-
The recent upsized share offering that raised new capital can support ongoing growth plans, but it also adds supply of stock to the market, which may weigh on valuation if expectations cool.
-
Ambiq Micro currently passes 0 of 6 valuation checks, which means the broader assessment leans expensive rather than suggesting obvious value according to the current score .
The stock's next move may depend on whether recent gains already reflect most of Ambiq Micro's potential or still leave room for further upside in the price investors are willing to pay.
Has Ambiq Micro Run Too Far on Sales?
P/S is a useful lens for Ambiq Micro because the company is still loss making, so revenue offers a clearer anchor than earnings. On this measure, Ambiq Micro currently trades on a P/S of about 24.3x, compared with a semiconductor industry average of 7.7x and a peer average of 3.3x. The Fair Ratio model, which blends factors such as the company's size, margins and risk profile, points to a P/S of around 9.8x as more typical.
Despite the recent upsized share offering that raised fresh capital for Ambiq Micro, the valuation suggests investors are paying a substantial premium to both peers and the modelled Fair Ratio. The current P/S sits well above those benchmarks and indicates that a lot of optimism about Ambiq Micro is already reflected in the price investors are paying for each dollar of sales.
On the P/S multiple, Ambiq Micro stock currently screens as overvalued relative to both its industry and the Fair Ratio benchmark.
See what the numbers say about this price — find out in our valuation breakdown.
The Ambiq Micro Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Ambiq Micro pick up where the valuation puzzle leaves off by spelling out which paths for Ambiq Micro's growth, margins and earnings would need to play out for today's high P/S multiple to look too low or too rich. Each narrative ties its number to a concrete view of how growth, profitability and risk could evolve, giving you a reference point you can revisit as fresh information comes through.
The community is split on Ambiq Micro, with one camp leaning into the edge AI story while the other questions how much is already priced in.
Bull case: roughly fairly valued
"Planned evolution of SPOT into a licensable IP and chip development platform for markets such as data center, automotive and mobile devices adds an asset light royalty and licensing stream, improving earnings quality, operating margin and cash generation over time..."
Read the full Bull Case to see why Ambiq Micro could be undervalued
Bear case: 17% overvalued
"Ambiq remains loss making despite gross margin improvements and plans to keep scaling R&D and go to market spending..."
Read the full Bear Case to see why Ambiq Micro could be overvalued
Do you think there's more to the story for Ambiq Micro? Head over to our Community to see what others are saying!
The Bottom Line
For Ambiq Micro, the current picture points to an overvalued stock on market multiples, with a wide gap between its P/S and both peers and the Fair Ratio benchmark. The broader valuation checks also lean weak, so the burden of proof now sits with the company to grow into the premium investors are paying. The key question from here is whether Ambiq Micro can deliver the growth, margin progress and scale that would make today's rich multiple feel sustainable rather than stretched.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include AMBQ .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
